Seoul, South Korea

Nam Gee Kim


Average Co-Inventor Count = 19.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Nam Gee Kim in Indene Derivatives

Introduction

Nam Gee Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of chemical technology, particularly in the development of indene derivatives. With a total of two patents to his name, his work focuses on innovative solutions for various metabolic and inflammatory disorders.

Latest Patents

Nam Gee Kim's latest patents include groundbreaking research on indene derivatives and their processes for preparation. These inventive indene derivatives are capable of selectively modulating the activities of peroxisome proliferator activated receptors (PPARs). This modulation is crucial as it causes no adverse side effects, making these derivatives useful for treating and preventing disorders such as metabolic syndromes, diabetes, obesity, arteriosclerosis, hyperlipidemia, hyperinsulinism, hypertension, and inflammatory diseases like osteoporosis, liver cirrhosis, asthma, and even cancer.

Career Highlights

Throughout his career, Nam Gee Kim has worked with esteemed organizations such as the Korea Research Institute of Chemical Technology and Jeil Pharm Co., Ltd. His experience in these institutions has allowed him to refine his expertise in chemical technology and patent development.

Collaborations

Nam Gee Kim has collaborated with notable colleagues, including Hyae Gyeong Cheon and Sung-eun Yoo. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Nam Gee Kim's innovative work in the field of indene derivatives showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various health disorders, highlighting the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…